William Kane - 22 Jul 2021 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
22 Jul 2021
Net transactions value
$0
Form type
4
Filing time
26 Jul 2021, 17:03:54 UTC
Next filing
13 Oct 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Options to Purchase Common Stock Award $0 +15,000 $0.000000 15,000 22 Jul 2021 Common Stock 15,000 $2.00 Direct F1
holding CTXR Options to Purchase Common Stock 25,000 22 Jul 2021 Common Stock 25,000 $1.69 Direct F2
holding CTXR Options to Purchase Common Stock 35,000 22 Jul 2021 Common Stock 35,000 $1.01 Direct F3
holding CTXR Options to Purchase Common Stock 25,000 22 Jul 2021 Common Stock 25,000 $1.39 Direct F4
holding CTXR Options to Purchase Common Stock 25,000 22 Jul 2021 Common Stock 25,000 $0.6700 Direct F5
holding CTXR Options to Purchase Common Stock 15,000 22 Jul 2021 Common Stock 15,000 $1.62 Direct F6
holding CTXR Options to Purchase Common Stock 10,000 22 Jul 2021 Common Stock 10,000 $3.45 Direct F7
holding CTXR Options to Purchase Common Stock 12,071 22 Jul 2021 Common Stock 12,071 $0.0150 Direct F8
holding CTXR Options to Purchase Common Stock 13,334 22 Jul 2021 Common Stock 13,334 $12.00 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in full on July 22, 2022.
F2 The options vest in full on February 16, 2022.
F3 The options vest in full on October 6, 2021.
F4 The options vest in full on July 7, 2021.
F5 The options vest in full on October 8, 2020.
F6 The options vest in full on September 4, 2019.
F7 The options vest in full on September 13, 2018.
F8 The options vested in 1/3 increments over a three-year period with the first installment vesting on March 28, 2015.
F9 The options vested in full on the first anniversary of the date of grant.